Emcure Pharmaceuticals

Emcure Pharmaceuticals Limited

Type	MNC (JVs and subsidiaries)
Industry	Pharmaceutical
Founded	1983
Headquarters	Hinjwadi, Pune, India
Key people	Satish Mehta CEO
Products	tablets, capsules, softgels, injectables, Lyophilized sterile parenterals, Onco products
Employees	approximately 9000
Website	www.emcure.co.in

Emcure Pharmaceuticals headquartered at Pune in West India is a vertically integrated Indian pharmaceutical company. The company's products include tablets, capsules (both softgel capsules and hard-gel capsules), and injectables.

Indian plants

• Solid Dosage facility at Hinjwadi - In 2006, Emcure received US FDA approval for its solid dosages facility at Hinjwadi, Pune. The plant manufactures solid oral formulations for the international regulated markets. With this approval, the facility has accreditation from US FDA, UK MHRA, WHO Geneva and MCC South Africa

• Small volume parenterals facility at Hinjwadi - USFDA and UK MHRA approved. Has lyophilization and pfs capability

• Onco injectable facility at Hinjwadi

• Solid Orals facilities at Jammu and Bhosari

• API manufacturing facility at Kurkumbh - USFDA approved

• Biotech facility at Hinjwadi

US plant

USA - The company has a manufacturing facility and R&D centre at East Brunswick, New Jersey, USA.

Capital markets

Emcure is planning to raise money through an initial public offering

Key products

Pharma Division

 1. Orofer XT ( Ferrous Ascorbate)
 2. Emsulide P
 3. Asomex (Chirally pure S-amlodipine)
 4. Pause (Tranexemic Acid)
 5. Infen (Dexketoprofen)
 6. Ferix 
 7. Nutriright 
 8. Metpure 
 9. Nutriright - d3
 10. Velidex
 11. Exhep

Recalls

There have been cases of drug recalls announced by Pharma majors like Pfizer & Teva after having manufactured their products with their partner Emcure. In 2010, Pfizer had to recalls three batches of a anti-bacterial product from the US market due to presence of Penicillium Chrysogenum in some samples . Teva recalls several batches of two products due to white tablets showing discoloration and presence of foreign particles in 2011

AIDS Initiative

Emcure voices its concerns on HIV/AIDS through its "Let's fight AIDS together" initiative and supplies Antiretroviral drugs to Africa, Asia Pacific and CIS. As a part of its corporate social responsibility it supports 'Taal', a pharmacy for HIV/AIDS patients run by HIV/AIDS patients.

Emcure has license agreements with Bristol-Myers Squibb for Atazanavir and Gilead Sciences for Tenofovir as part of their Global Access Programs.

Anticancer portfolio

Roche has signed a deal with Emcure for manufacturing its blockbuster anticancer drugs Herceptin and Mabthera in India. This is the first time that an Indian company has bagged a biological drug manufacturing contract . Under this programme the cancer drugs shall be made available to the developing world at an affordable 'cut-price' version . The monthly doses priced at around $3000 are expected to be slashed significantly for wider access to cancer therapy.

Group Companies

• Emcure USA http://www.emcureusa.com/
• Gennova http://www.emcure.co.in/group_Gennova.asp
• Zuventus http://www.zuventus.co.in:8080/jsp/default.jsp

External links

• Emcure website
• [1]
• Specializing in Chiral chemistry
• Project Disha
• Emcure Hinjwadi site
• Emcure Pharmaceuticals Limited Presents at 2nd Annual NDDS India 2011
• Emcure presents at the Workshop on Chem Sciences & Tech., IYC 2011 at National Chemical Lab., Pune